EMHA launches the first Migraine Friendly Workplace Stamp. This new initiative is designed to reduce the impact of migraine in the workplaceand recognizes companies that undertake EMHA training as well as making actionablechange in the workplace. Migraine affects over 41 million adults in Europe (prevalence 14%)1 and as migraine peaksduring individuals’ most productive years of …
As part of EFNA’s Training Initiatives for Neurology Advocates [TINA] programme, a new series of e-learning modules is launched today, on the theme of personalised healthcare. Personalised medicine is a medical model that aims to provide tailor-made prevention and treatment strategies for defined groups of individuals. This usually involves genomics, information technology and patient empowerment. However, at EFNA, we feel …
New e-learning series on Personalized Healthcare Read More »
The Migraine Movement, led by the EMHA, was awarded 3 important prizes during this year. The EFNA advocacy awards announced the EMHA and Elena Ruiz de la Torre, executive director of the association, as the 2021 winner. This honorable recognition, puts on the spotlight all the hard work the EMHA has been doing to give …
Within the documentary ‘Essentials: The role of patients’ associations in the health and social system in the COVID era’ we present a series of interviews with the associations. In this interview, AEMICE talks with Elena Ruiz de la Torre on the importance of the patient’s role in the health system. “We have been in quarantine …
Encouraging and participating in research that adds value to our members, as well as to all migraine patients, is one of the goals we are constantly working towards. The voice of patients needs to be represented in scientific migraine papers. By doing so, we are contributing to improving the possitive impact all the findings could …
Women at Work results from Migraine at Work survey. 7 Countries 7 Languages : France, Spain, Germany, Italy, Portugal, UK and Denmark. 3.350 responders – > 3.008 women. 30 question in three blocks: a.- socio-demographic questions b.- disease questions c.- questions related to their post and real burden
The Italian senate has approved the recognition of primary chronic headache as a social disease, a huge step towards the acknowledgment of migraine as the serious illness it is. On April 18, 2019 the Chamber passed the bill and 15 months later it was finally approved by the Italian Senate. This achievement reflects the struggle …
Chronic Migraine is officially regulated as a social disease in Italy Read More »
Learn more about migraine, its symptoms, causes, history and key facts.
All the articles are based on the survey led by EMHA on Migraine at work. Read the survey on the following link to find out more about the study: https://www.emhalliance.org/wp-content/uploads/2020/01/EMHA-Migraine-at-work.pdf SEMERGEN publication European Survey on preventive treatments on migraine Medicina Balear Magazine EMHA at Work: SED Publication Survey
Watch the first webinar for patients on Covid-19 and its impact on migraine and other headaches streamed by Vall d’Hebron Hospital with the support of EMHA.
Learn about the impact of the virus on patients with migraine, the possible risks associated with the treatments and advice on reducing the negative impact of the lock down during migraine and other headaches episodes.
